Novartis AG
Patents, Design & Utilities
Last updated:
List of all Novartis AG patents 1,223 in total
| Status | Patent |
|---|---|
Grant | Utility: Process for manufacturing contact lenses Filling date: 23 Sep 2025 Issue date: 7 Apr 2020 |
Application | Utility: COMBINATION THERAPY Filling date: 23 Sep 2025 Issue date: 2 Apr 2020 |
Grant | Utility: Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase Filling date: 23 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Multi-beam splitting using spatial beam separation Filling date: 23 Sep 2025 Issue date: 31 Mar 2020 |
Grant | Utility: Substituted 5-cyanoindole compounds and uses thereof Filling date: 23 Sep 2025 Issue date: 31 Mar 2020 |
Application | Utility: NEW METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS Filling date: 23 Sep 2025 Issue date: 26 Mar 2020 |
Grant | Utility: Soft silicone medical devices with durable lubricious coatings thereon Filling date: 23 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Amphiphilic branched polydiorganosiloxane macromers Filling date: 23 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Tablet formulation of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl) imidazo [1,2-B] [1,2,4] triazin-2-yl] benzamide Filling date: 23 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Compounds and compositions for the treatment of parasitic diseases Filling date: 23 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Pazopanib formulation Filling date: 23 Sep 2025 Issue date: 24 Mar 2020 |
Grant | Utility: Beta-lactamase inhibitors Filling date: 23 Sep 2025 Issue date: 24 Mar 2020 |
Application | Utility: COMBINATION OF CERTINIB WITH AN EGFR INHIBITOR Filling date: 23 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: Methods of Treating Palmoplantar Pustular Psoriasis (PPP) Using IL-17 Antagonists Filling date: 23 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: THERAPEUTIC REGIMENS FOR CHIMERIC ANTIGEN RECEPTOR THERAPIES Filling date: 23 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES Filling date: 23 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: BIOMARKERS AND CAR T CELL THERAPIES WITH ENHANCED EFFICACY Filling date: 23 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: CALCULATION OF ACTUAL ASTIGMATISM CORRECTION AND NOMOGRAPHS FOR CORNEAL LASER TREATMENT Filling date: 23 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: METHODS OF TREATING FGF21-ASSOCIATED DISORDERS Filling date: 23 Sep 2025 Issue date: 19 Mar 2020 |
Grant | Utility: Contact lens inspection method and system Filling date: 23 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Colored hydrogel contact lenses with lubricious coating thereon Filling date: 23 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Cyano-substituted indoles as LSD1 inhibitors Filling date: 23 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Intraocular lens injector Filling date: 23 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Fatty acids and their use in conjugation to biomolecules Filling date: 23 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE Filling date: 23 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: SYSTEMS AND METHODS FOR PULSED POSTERIOR VITREOUS DETACHMENT CREATION Filling date: 23 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS Filling date: 23 Sep 2025 Issue date: 12 Mar 2020 |
Grant | Utility: Methods of treating psoriasis using IL-17 antibodies Filling date: 23 Sep 2025 Issue date: 10 Mar 2020 |
Application | Utility: SURGICAL SYSTEMS INCLUDING A POWER LOSS MITIGATION SUBSYSTEM Filling date: 23 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: DEVICES AND METHODS FOR A CANNULA-DELIVERED TREATMENT MATERIAL APPLICATION DEVICE Filling date: 23 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR Filling date: 23 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: PIERCING MECHANISM AND CARTRIDGE PIERCING SYSTEM Filling date: 23 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: Dosing schedule for a combination of Ceritinib and an anti-PD-1 antibody molecule Filling date: 23 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: SYSTEM FOR USE OF A PHARMACEUTICAL PRODUCT Filling date: 23 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: Flexible, hermetic electrical interconnect for electronic and optoelectronic devices for in vivo use Filling date: 23 Sep 2025 Issue date: 3 Mar 2020 |
Grant | Utility: Angiopoietin-like 4 antibodies and methods of use Filling date: 23 Sep 2025 Issue date: 3 Mar 2020 |
Grant | Utility: Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Filling date: 23 Sep 2025 Issue date: 3 Mar 2020 |
Application | Utility: METHODS FOR PREPARING SQUALENE Filling date: 23 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: METHOD AND APPARATUS FOR PERFORMING OPHTHALMIC PROCEDURES REMOVING UNDESIRABLE FEATURES USING LASER ENERGY Filling date: 23 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: METHODS OF ENHANCING IMMUNE RESPONSE Filling date: 23 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: Drug Delivery Systems Filling date: 23 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: CHIMERIC ANTIGEN RECEPTOR THERAPY CHARACTERIZATION ASSAYS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 27 Feb 2020 |
Grant | Utility: Apparatus for modelling ocular structures Filling date: 23 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Intraocular lens injector Filling date: 23 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Diamino pyridine derivatives Filling date: 23 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Adjusting the apodization pattern for diffractive IOLs Filling date: 23 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Stable and soluble antibodies Filling date: 23 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Treatment of cancer using a CLL-1 chimeric antigen receptor Filling date: 23 Sep 2025 Issue date: 25 Feb 2020 |
Grant | Utility: Methods for treating hematologic cancers Filling date: 23 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: Method of Adjuvant Cancer Treatment Filling date: 23 Sep 2025 Issue date: 20 Feb 2020 |
Showing 900 to 950 of 1223 patents.